Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients

<div>Construction and validation of the nomogram. (a, b) Nomograms of the TCGA and GEO cohorts were used to predict 1-, 3-, and 5-year survival probabilities in OV patients. (c, d) In the TCGA and GEO cohorts, calibration curves of nomograms showed the relationship between predicted and actual curves.</div>

Journal of Immunology Research

fig4

Figure 4

Figure 4: Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients 